Floatz logo

Allogeneic Mesenchymal Stem Cells

Alcoholic Liver Cirrhosis

Stempeutics Research Pvt LtdCell therapyPhase 2Dormant
B
57/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
42/ 100
Competitive Position
95/ 100

Competitive context

6 Active assets in the Alcoholic Liver Cirrhosis cohort.

Asset / SponsorPhaseRating
Losartan
Odense University Hospital
Phase 4BB
Cellgram-Lc
Pharmicell Co., Ltd.
Phase 3B
Livercellgram
Pharmicell Co., Ltd.
Phase 2B
S-Adenosyl-L-Methionine
Indiana University
Phase 2CCC
FILGRASTIM
Yaqrit Ltd
Phase 2CCC

View all 11 →

Same molecule, other indications

Allogeneic Mesenchymal Stem Cells is also rated in:

ischemic strokeDormant
CCC
Indicative ·
51 / 100
View asset →
stroke disorderDormant
CC
Indicative ·
41 / 100
View asset →
Wilson diseaseDormant
D
Indicative ·
30 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →